R&D Systems™ Recombinant Human Insulin R/CD220 (aa 28-944) Protein

Catalog No.	Formulation
1544IR050CF	Lyophilized from a 0.2μm filtered solution in PBS.
1544IR050	Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.

Catalog No. 1544IR050CF Supplier R&D Systems™ Supplier No. 1544IR050/CF

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

The Recombinant Human Insulin R/CD220 (aa 28-944) Protein is derived from NS0. The Recombinant Human Insulin R/CD220 (aa 28-944) Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 3643
• Molecular Weight (g/mol): 82.9 kDa ( alpha subunit), 22.9 kDa (beta subunit)
• Name: Insulin R/CD220
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human Insulin R/CD220 protein His28-Arg750 ( alpha subunit) & Ser751-Lys944 with a C-terminal 10-His tag ( beta subunit)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Tetramer; disulfide-linked homodimer of disulfide-linked heterodimers ( alpha & beta )
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 90%, by SDS-PAGE under reducing conditions and visualized by silver stain.